Detailed examination of DNA methylation and other epigenetic modifications of genes such as SLC1A2 in response to addictions comorbid with BD may allow for the discovery of both diagnostic and treatment response biomarkers (Guidotti et al., 2013). Here, SLC1A2 is linked to Behcet disease.